Canopy Growth Corporation (CGC)
After hours:
| Previous close | 7.16 |
| Open | 7.25 |
| Bid | 7.25 x 1200 |
| Ask | 7.33 x 600 |
| Day's range | 7.18 - 7.43 |
| 52-week range | 2.76 - 19.20 |
| Volume | |
| Avg. volume | 8,962,927 |
| Market cap | 750.053M |
| Beta (5Y monthly) | 1.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 7-15-24
Key Takeaways; Cannabis Sector Canopy Growth received ISS recommendation for creation of exchangeable shares. Trulieve to hold first quarter 2024 results conference call at the beginning of May. Goodness Growth announced sale of Vireo Health of New York in effort to address financial constraints. Avant Brands entered German market through IM Cannabis deal. Key Takeaways; […]
- Simply Wall St.
Calculating The Fair Value Of Canopy Growth Corporation (TSE:WEED)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Canopy Growth fair value estimate is CA$8.19 With CA$9.74...
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 6-10-24
Key Takeaways; Cannabis Sector Canopy Growth to fully acquire Acreage Holdings in strategic move AFC Gamma exited its largest portfolio loan, securing 19.9% return. Green Thumb CEO confirmed proposal to Boston Beer. Scotts Miracle-Gro adjusted financial outlook for 2024 but maintained strategic goals. Key Takeaways; Psychedelic Sector Filament Health received FDA approval for a meth […]
